Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.
Broderick Brian C Increases Stake in Roche Holding Ltd. (RHHBY)
Get Analysts' Upgrades and Downgrades Daily
Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.
A number of other institutional investors have also recently bought and sold shares of the company. Rothschild Investment Corp IL increased its position in Roche Holding by 0.7% in the first quarter. Rothschild Investment Corp IL now owns 16,142 shares of the company’s stock worth $517,000 after buying an additional 113 shares during the period. Delaney Dennis R increased its position in Roche Holding by 1.8% in the first quarter. Delaney Dennis R now owns 7,625 shares of the company’s stock worth $244,000 after buying an additional 135 shares during the period. Fayerweather Charles increased its position in Roche Holding by 2.8% in the first quarter. Fayerweather Charles now owns 15,539 shares of the company’s stock worth $497,000 after buying an additional 425 shares during the period. Moloney Securities Asset Management LLC increased its position in Roche Holding by 5.9% in the first quarter. Moloney Securities Asset Management LLC now owns 9,560 shares of the company’s stock worth $305,000 after buying an additional 534 shares during the period. Finally, Jolley Asset Management LLC increased its position in Roche Holding by 1.3% in the second quarter. Jolley Asset Management LLC now owns 46,445 shares of the company’s stock worth $1,477,000 after buying an additional 600 shares during the period.
Shares of Roche Holding Ltd. (RHHBY) traded down 0.53% during trading on Monday, reaching $32.10. The company’s stock had a trading volume of 104,738 shares. The company’s 50-day moving average price is $32.21 and its 200 day moving average price is $31.73. The stock has a market capitalization of $218.78 billion and a price-to-earnings ratio of 22.22. Roche Holding Ltd. has a 1-year low of $25.25 and a 1-year high of $36.82.
COPYRIGHT VIOLATION NOTICE: This report was first reported by [[site]] and is the property of of [[site]]. If you are accessing this report on another publication, it was illegally stolen and republished in violation of US & international copyright and trademark legislation. The original version of this report can be accessed at [[permalink]].
A number of equities analysts recently commented on the company. BNP Paribas reiterated a “neutral” rating on shares of Roche Holding in a research note on Tuesday, June 20th. UBS AG downgraded Roche Holding from a “buy” rating to a “neutral” rating in a research note on Thursday, July 6th. Cowen and Company set a $38.00 price target on Roche Holding and gave the stock a “buy” rating in a research note on Monday, July 10th. Societe Generale downgraded Roche Holding from a “buy” rating to a “hold” rating in a research note on Friday, June 30th. Finally, HSBC Holdings plc downgraded Roche Holding from a “hold” rating to a “reduce” rating in a research note on Friday, April 7th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company. The company has an average rating of “Hold” and an average price target of $37.00.
Roche Holding Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding Ltd. (NASDAQ:RHHBY).